K. Stegmeier
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Surgery 9
- Cholesterol and Lipid Metabolism 7
-
- Inflammatory mediators and NSAID effects 4
- Pharmacology and Obesity Treatment 4
- Co-authors
- H. Patscheke (7 shared papers)J. Pill (11 shared papers)H. Dariush Fahimi (3 shared papers)F. H. Schmidt (4 shared papers)Sadaki Yokota (1 shared paper)Johannes Aufenanger (4 shared papers)B. Müller‐Beckmann (4 shared papers)Johannes Pill (2 shared papers)
- Journals
- Annals of the New York Academy of Sciences (3 papers)Thrombosis Research (2 papers)Hormone and Metabolic Research (2 papers)European Journal of Clinical Pharmacology (1 paper)Thrombosis and Haemostasis (1 paper)
- Partner nations
- GermanyUnited StatesIsrael
In The Last Decade
K. Stegmeier
29 papers receiving 540 citations
Peers
Comparison fields: 5 of 73
- Clinical Biochemistry 75
- Biochemistry 70
- Pharmacology 112
- Cardiology and Cardiovascular Medicine 112
- Internal Medicine 14
Countries citing papers authored by K. Stegmeier
This map shows the geographic impact of K. Stegmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Stegmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Stegmeier more than expected).
Fields of papers citing papers by K. Stegmeier
This network shows the impact of papers produced by K. Stegmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Stegmeier. The network helps show where K. Stegmeier may publish in the future.
Co-authors
The 25 scholars most cited alongside K. Stegmeier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 112 | |
| 2 | 1984 | 89 | |
| 3 | 1984 | 73 | |
| 4 | 1986 | 39 | |
| 5 | 1978 | 38 | |
| 6 | Proliferation of peroxisomes in pericentral hepatocytes of rat liver after administration of a new hypocholesterolemic agent (BM 15766). Sex-dependent ultrastructural differences. | 1987 | 31 |
| 7 | 1982 | 21 | |
| 8 | 1985 | 19 | |
| 9 | Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death. | 1984 | 18 |
| 10 | 1982 | 17 | |
| 11 | 1987 | 13 | |
| 12 | 1986 | 13 | |
| 13 | 1987 | 12 | |
| 14 | 1986 | 9 | |
| 15 | 1985 | 8 | |
| 16 | 1991 | 8 | |
| 17 | 1996 | 8 | |
| 18 | 1985 | 7 | |
| 19 | Investigations of the antiatherosclerotic effect of the thromboxane A2 receptor antagonist Daltroban. | 1990 | 6 |
| 20 | Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis. | 1990 | 6 |
About K. Stegmeier
K. Stegmeier is a scholar working on Surgery, Pharmacology, Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 29 papers that have together received 573 indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (4 papers), Pharmacology and Obesity Treatment (4 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Liver Disease Diagnosis and Treatment (3 papers), Cancer, Lipids, and Metabolism (3 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). The work is most often cited by research in Clinical Biochemistry (75 citations), Biochemistry (70 citations), Pharmacology (112 citations), Cardiology and Cardiovascular Medicine (112 citations) and Internal Medicine (14 citations). K. Stegmeier has collaborated with scholars based in Germany, United States and Israel. Frequent co-authors include H. Patscheke, J. Pill, H. Dariush Fahimi, F. H. Schmidt, Sadaki Yokota, Johannes Aufenanger, B. Müller‐Beckmann, Johannes Pill, G. Neugebauer and Fahimi Hd. Their work appears in journals such as Annals of the New York Academy of Sciences, Thrombosis Research, Hormone and Metabolic Research, European Journal of Clinical Pharmacology and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.